Cargando…
Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2–4
Hereditary proximal spinal muscular atrophy causes weakness and increased fatigability of repetitive motor functions. The neuromuscular junction is anatomically and functionally abnormal in patients with spinal muscular atrophy. Pharmacological improvement of neuromuscular transmission may therefore...
Autores principales: | Stam, Marloes, Wijngaarde, Camiel A, Bartels, Bart, Asselman, Fay-Lynn, Otto, Louise A M, Habets, Laura E, van Eijk, Ruben P A, Middelkoop, Bas M, Goedee, H Stephan, de Groot, Janke F, Roes, Kit C B, Schoenmakers, Marja A G C, Nieuwenhuis, Edward E S, Cuppen, Inge, van den Berg, Leonard H, Wadman, Renske I, van der Pol, W Ludo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825780/ https://www.ncbi.nlm.nih.gov/pubmed/36632180 http://dx.doi.org/10.1093/braincomms/fcac324 |
Ejemplares similares
-
Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2–4 (SPACE trial)
por: Stam, Marloes, et al.
Publicado: (2018) -
Assessment of fatigability in patients with spinal muscular atrophy: development and content validity of a set of endurance tests
por: Bartels, Bart, et al.
Publicado: (2019) -
Fatigability in spinal muscular atrophy: validity and reliability of endurance shuttle tests
por: Bartels, Bart, et al.
Publicado: (2020) -
Quantitative MRI of skeletal muscle in a cross‐sectional cohort of patients with spinal muscular atrophy types 2 and 3
por: Otto, Louise A.M., et al.
Publicado: (2020) -
Limited maximal mouth opening in patients with spinal muscular atrophy complicates endotracheal intubation: An observational study
por: Wijngaarde, Camiel A., et al.
Publicado: (2018)